Yamanouchi attempts to use its drug delivery business (Yamanouchi Shaklee Pharma) to help jumpstart its efforts to gain a foothold in the US and to eventually become a true global player. Yamanouchi's support of YSP may, however, be a two-edged sword: it provides YSP with the kind of financial support that most drug delivery companies can only dream of, but it may also scare off potential partners.
by Jeffrey Dvorin
A tour of Yamanouchi Shaklee Pharma 's (YSP) new Palo Alto facilities provides striking evidence of its ambitious plans for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights